Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
44
INVZ Quote, Financials, Valuation and Earnings
Last price:
$0.90
Seasonality move
:
-22.2%
Day range:
$0.86 - $0.91
52-week range:
$0.45 - $3.14
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.50x
P/B ratio:
1.67x
Volume:
1.5M
Avg. volume:
3.3M
1-year change:
-12.21%
Market cap:
$179.9M
Revenue:
$24.3M
EPS (TTM):
-$0.46
Innoviz Technologies Number of Institutional Trades
Innoviz Technologies Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$80.6M
(Last 6 Months)
Current Institutional Ownership Percentage
25.91%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$253.6M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Innoviz Technologies Institutional Ownership
-
What Percentage Of INVZ Is Owned by Institutions?
25.91% of INVZ is owned by institutions.
-
How Many Institutions Own INVZ Shares?
Innoviz Technologies stock is owned by 167 institutional shareholders at this time.
-
Have Institutions Been Buying INVZ Stock?
Yes, institutions have bought 53.3M shares of INVZ in the last quarter.
-
Have Institutions Been Selling INVZ Stock?
Yes, institutions have sold 117.7M shares of INVZ over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
